在用L-卡诺辛治疗后,慢性缩性胃炎的改善
Rudi De Bastiani1, Matteo Fassan2,3, Gianluca Businello2
1GIGA-CP Italian Association for Primary Care Gastroenterology, Feltre, Italy.
The American journal of case reports
|November 20, 2025
概括
L-卡诺辛补充剂改善了慢性缩性胃炎 (CAG) 的症状和组织学特征. 这种药物可能有助于降低CAG患者胃癌进展的风险.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性缩性胃炎 (CAG) 是胃癌的重要危险因素,特别是在肠道转化时.
- 虽然H. pylori根除是标准的,但CAG逆转的替代疗法是有限的.
- 对于胃粘膜损伤,正在探索具有排毒,抗氧化和抗炎性能的药物.
研究的目的:
- 评估L-卡诺辛在治疗慢性缩性胃炎 (CAG) 的疗效.
- 评估L-卡诺辛对CAG消化不良症状和组织学特征的影响.
- 探索其在预防胃癌进展方面的潜在作用.
主要方法:
- 两例CAG病例报告 (自身免疫和H.pylori诱导) 用口服L-卡诺辛 (39.5毫克每天两次) 治疗至少12个月.
- 在治疗12个月后进行内镜和组织学重新评估.
- 胃功能标志物的监测:素I,素II和胃素 17.
主要成果:
- 在这两位患者中报告的消化不良症状显著改善.
- 慢性缩性胃炎的组织学特征显示临床显著改善.
- 胃功能的改善标志物 (pepsinogen I/II,胃素17水平) 支持的有益作用.
结论:
- L-卡诺辛在改善CAG的症状和组织学结果方面表现有前途.
- 长期治疗可能会降低向胃癌发展的风险.
- 需要进行更大规模的临床研究来验证这些发现并制定治疗指南.
相关概念视频
Peptic Ulcer Disease IV: Management
407
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
407
Gastritis III: Clinical Manifestations and Management
1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
Gastritis-II: Pathophysiology
1.1K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K
Gastritis-I: Introduction and Types
2.1K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.1K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
607
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
607


